Recent News

• 06.05.2026 - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.03.2026 - New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology
• 05.26.2026 - Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference
• 05.08.2026 - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.06.2026 - Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update

Recent Filings

• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.11.2026 - 144 Report of proposed sale of securities
• 05.11.2026 - 144 Report of proposed sale of securities
• 05.08.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2026 - 8-K Current report
• 05.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.06.2026 - 4 Statement of changes in beneficial ownership of securities